Michael S. Schwartz
- Molecular Medicine top 5%
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy 7
- Microbial Natural Products and Biosynthesis 3
- Infectious Diseases top 5%
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 7
- Microbial Natural Products and Biosynthesis 3
-
- Microbial Metabolism and Applications 5
-
- Plant biochemistry and biosynthesis 5
-
- Metabolism and Genetic Disorders 3
-
- Lipoproteins and Cardiovascular Health 3
-
- Mass Spectrometry Techniques and Applications 3
-
- Pesticide Residue Analysis and Safety 3
- Co-authors
- R.J. StubbsW.F. BayneB.K. MatuszewskiRobert B. StanleyMoshe PhillipLiat de VriesGadi HorevElizabeth B. Hirsch
- Journals
- The Journal of Clinical Endocrinology & Metabolism (1 paper)American Journal of Respiratory and Critical Care Medicine (1 paper)Journal of Applied Physiology (1 paper)
- Partner nations
- United StatesIsraelNorway
In The Last Decade
Michael S. Schwartz
42 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 108
- Molecular Medicine 160
- Applied Microbiology and Biotechnology 58
- Pharmacology 375
- Infectious Diseases 362
- Pharmacology 147
Countries citing papers authored by Michael S. Schwartz
This map shows the geographic impact of Michael S. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Schwartz more than expected).
Fields of papers citing papers by Michael S. Schwartz
This network shows the impact of papers produced by Michael S. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Schwartz. The network helps show where Michael S. Schwartz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael S. Schwartz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 25 | |
| 2 | 2018 | 29 | |
| 3 | 2008 | 12 | |
| 4 | 2008 | 43 | |
| 5 | 2006 | 103 | |
| 6 | 2004 | 16 | |
| 7 | 2003 | 16 | |
| 8 | 2002 | 4 | |
| 9 | 1999 | 68 | |
| 10 | 1999 | 4 | |
| 11 | 1999 | 26 | |
| 12 | 1998 | 6 | |
| 13 | 1997 | 7 | |
| 14 | 1995 | 4 | |
| 15 | 1994 | 33 | |
| 16 | 1992 | 86 | |
| 17 | 1992 | 18 | |
| 18 | 1991 | 8 | |
| 19 | 1991 | 129 | |
| 20 | 1990 | 25 |
About Michael S. Schwartz
Michael S. Schwartz is a scholar working on Applied Microbiology and Biotechnology, Pharmacology and Biotechnology, having authored 42 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Microbial Metabolism and Applications (5 papers), Plant biochemistry and biosynthesis (5 papers), Microbial Natural Products and Biosynthesis (3 papers), Metabolism and Genetic Disorders (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Mass Spectrometry Techniques and Applications (3 papers) and Pesticide Residue Analysis and Safety (3 papers). The work is most often cited by research in Molecular Medicine (160 citations), Applied Microbiology and Biotechnology (58 citations) and Pharmacology (375 citations). Michael S. Schwartz has collaborated with scholars based in United States, Israel and Norway. Frequent co-authors include R.J. Stubbs, W.F. Bayne, B.K. Matuszewski, Robert B. Stanley, Moshe Phillip, Liat de Vries, Gadi Horev, Elizabeth B. Hirsch, Kimberly R. Ledesma and Mary Motyl. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, American Journal of Respiratory and Critical Care Medicine and Journal of Applied Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.